Addex Therapeutics (ADXN) Other Operating Expenses (2018 - 2024)
Addex Therapeutics (ADXN) posted Other Operating Expenses of -$9.4 million for Q4 2024, down 4.0175574611845473e+18% sequentially from $0.0 in Q1 2024, and up 12.75% YoY from -$8.3 million in Q1 2024.
Addex Therapeutics (ADXN) Other Operating Expenses (2018 - 2024) Analysis & Trends
Addex Therapeutics has reported Other Operating Expenses for 7 years, with the latest figure at -$9.4 million in Q4 2024.
- Quarterly Other Operating Expenses rose 12.75% year-over-year to -$9.4 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was -$9.4 million (up 12.75% YoY) and the FY2024 annual result came in at -$0.0, changed N/A from the prior year.
- Other Operating Expenses retreated to -$9.4 million in Q4 2024 per ADXN's latest filing, from $0.0 in the prior quarter.
- Over five years, Other Operating Expenses peaked at $0.0 in Q3 2022 and troughed at -$49.3 million in Q4 2021.
- A 5-year average of -$17.8 million and a median of -$9.4 million in 2024 frame the typical range for Other Operating Expenses.
- The sharpest annual moves came in 2021 and 2023: Other Operating Expenses slipped 14.8% in 2021, then jumped 76.8% in 2023.
- Over 5 years, Other Operating Expenses stood at -$43.0 million in 2020, then fell by 14.8% to -$49.3 million in 2021, then climbed by 6.31% to -$46.2 million in 2022, then surged by 76.8% to -$10.7 million in 2023, then climbed by 12.75% to -$9.4 million in 2024.
- According to Business Quant data, Other Operating Expenses over the past three periods registered -$9.4 million, $0.0, and -$10.7 million for Q4 2024, Q1 2024, and Q4 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -9.35 Mn |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | -10.72 Mn |
| Dec 31, 2022 | -46.21 Mn |
| Sep 30, 2022 | 0.00 |
| Dec 31, 2021 | -49.33 Mn |
| Dec 31, 2020 | -42.97 Mn |
| Sep 30, 2020 | 0.00 |
| Jun 30, 2020 | -1.37 Mn |
| Dec 31, 2019 | -43.32 Mn |
| Sep 30, 2019 | 0.00 |
| Dec 31, 2018 | -4.94 Mn |